Elias Sotirchos

GFAP: a potential biomarker for progression in MS 1:31
GFAP: a potential biomarker for progression in MS
Elias Sotirchos • 27 Feb 2023
Longitudinal studies to bring sNfL to MS clinical practice 1:13
Longitudinal studies to bring sNfL to MS clinical practice
Elias Sotirchos • 27 Feb 2023
Interpretation of serum NfL depends on the selection of a reference population 4:41
Interpretation of serum NfL depends on the selection of a reference population
Elias Sotirchos • 27 Feb 2023
Retinal atrophy independent of optic neuritis in AQP4+ NMOSD 6:47
Retinal atrophy independent of optic neuritis in AQP4+ NMOSD
Elias Sotirchos • 18 Oct 2021
Elevated sNfL associated with brain atrophy and new T2 lesions 4:26
Elevated sNfL associated with brain atrophy and new T2 lesions
Elias Sotirchos • 18 Oct 2021
Serum neurofilament light chain levels as a biomarker in MS 4:48
Serum neurofilament light chain levels as a biomarker in MS
Elias Sotirchos • 23 Feb 2021
ACTRIMS highlights: aging, emerging concepts, and visual pathways 1:13
ACTRIMS highlights: aging, emerging concepts, and visual pathways
Elias Sotirchos • 23 Feb 2021
Assessing novel biomarkers: retinal layer atrophy in PMS vs. RRMS 2:28
Assessing novel biomarkers: retinal layer atrophy in PMS vs. RRMS
Elias Sotirchos • 23 Feb 2021
The content of VJNeurology is intended for healthcare professionals